menu
    • menu

    Company profile for MedAlliance

    NEW Drugs in Dev: 1
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MedAlliance is a privately-owned medical technology company. It is headquartered in Nyon, Switzerland, with facilities in Irvine CA, Glasgow UK and Singapore. MedAlliance has been dedicated to developing innovative drug-eluting balloons (DEBs) for patients suffering from life-threating coronary and peripheral arterial disease. Using breakthrough proprietary technology, MedAlliance has found a unique solution to the challeng...
    MedAlliance is a privately-owned medical technology company. It is headquartered in Nyon, Switzerland, with facilities in Irvine CA, Glasgow UK and Singapore. MedAlliance has been dedicated to developing innovative drug-eluting balloons (DEBs) for patients suffering from life-threating coronary and peripheral arterial disease. Using breakthrough proprietary technology, MedAlliance has found a unique solution to the challenge of controlled and sustained sirolimus release with SELUTION SLR™.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MedAllianceSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    M.A. Med Alliance SA MedAlliance CardioVascular SA
    Telephone
    Telephone
    + 41 22 363 78 90
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://medalliance.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Cosmoprof

    Cosmoprof

    Not Confirmed

    envelop Contact Supplier

    Cosmoprof

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MedAlliance acquired by Cordis for $1.13 billion
    MedAlliance acquired by Cordis for $1.13 billion

    17 Nov 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/medalliance-acquired-by-cordis-for-1-13-billion/articleshow/105311536.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    17 Nov 2023
    Share Share
    MedAlliance Announces Enrollment of 1,660 Patients in SELUTION DeNovo Study
    MedAlliance Announces Enrollment of 1,660 Patients in SELUTION DeNovo Study

    14 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/medalliance-announces-enrollment-of-over-1-660-patients-in-landmark-selution-denovo-study-301927601.html

    PR NEWSWIRE
    14 Sep 2023
    Share Share
    MedAlliance announces enrollment of First Patient in SELUTION SLR LOVE-DEB
    MedAlliance announces enrollment of First Patient in SELUTION SLR LOVE-DEB

    05 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/medalliance-announces-enrollment-of-first-patient-in-selution-slr-love-deb-coronary-study-301917620.html

    PR NEWSWIRE
    05 Sep 2023
    Share Share
    MedAlliance announces completion of enrollment in SAVE Trial with SELUTION SLR
    MedAlliance announces completion of enrollment in SAVE Trial with SELUTION SLR

    16 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/medalliance-announces-the-completion-of-enrollment-in-save-trial-with-selution-slr-for-treatment-of-av-fistulas-in-renal-dialysis-patients-301899997.html

    PR NEWSWIRE
    16 Aug 2023
    Share Share
    MedAlliance announces completion of enrollment in SAVE Trial with SELUTION SLR
    MedAlliance announces completion of enrollment in SAVE Trial with SELUTION SLR

    15 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/medalliance-announces-the-completion-of-enrollment-in-save-trial-with-selution-slr-for-treatment-of-av-fistulas-in-renal-dialysis-patients-301899987.html

    PR NEWSWIRE
    15 Aug 2023
    Share Share
    MedAlliance SELUTION SLR is the 1st DEB to receive coronary de novo IDE approval
    MedAlliance SELUTION SLR is the 1st DEB to receive coronary de novo IDE approval

    10 Jan 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/medalliance-selution-slr-is-the-first-deb-to-receive-coronary-de-novo-ide-approval-its-fourth-fda-ide-deb-approval-301717597.html

    PR NEWSWIRE
    10 Jan 2023
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search